# Reference: Investigations View (= Projects) + Documents View (= Education) > Extracted from goal.md — Investigations and Documents sections. Two simpler views that share the expandable-row pattern. --- ## Investigations View (= Projects) Projects presented as diagnostic investigations — tests that were ordered, performed, and returned results. ### Investigation List ``` +--[ Investigation Results ]----------------------------------------------+ | Test Name | Requested | Status | Result | |------------------------------+-----------+----------+-------------------| | PharMetrics Interactive | 2024 | Complete | Live (green) | | Platform | | | | | Patient Switching Algorithm | 2025 | Complete | 14,000 pts found | | Blueteq Generator | 2023 | Complete | 70% reduction | | CD Monitoring System | 2024 | Complete | Population-scale | | Sankey Chart Analysis Tool | 2023 | Complete | Pathway audit | | Patient Pathway Analysis | 2024 | Ongoing | In development | +-------------------------------------------------------------------------+ ``` ### Status Badges Styled like laboratory result status indicators: - **Complete** (green dot): Investigation finished, results available - **Ongoing** (amber dot): Investigation still in progress - **Live** (pulsing green dot): Results are actively being used (for PharMetrics, which is a live URL) ### Expanded Investigation View Clicking an investigation row reveals a detailed "results panel" below the row: ``` PharMetrics Interactive Platform |-- Date Requested: 2024 |-- Date Reported: 2024 |-- Status: Complete - Live at medicines.charlwood.xyz |-- Requesting Clinician: A. Charlwood |-- Methodology: | Real-time medicines expenditure dashboard providing | actionable analytics for NHS decision-makers. Built with | Power BI and SQL, tracking expenditure across the 220M | prescribing budget. |-- Results: | - Real-time tracking of medicines expenditure | - Actionable analytics for budget holders | - Self-serve model for wider team |-- Tech Stack: Power BI, SQL, DAX |-- [View Results ->] (external link to medicines.charlwood.xyz) ``` The expanded view uses a tree-like indented structure (with box-drawing characters in monospace) to present the investigation report. This mirrors how lab results and imaging reports appear in clinical systems — structured, indented, with labelled fields. ### "View Results" Link For PharMetrics (the only project with a live URL), a "View Results" button appears styled as an NHS blue action button. For internal projects, this button is absent. --- ## Documents View (= Education & Certifications) Education and certifications presented as attached documents in the patient record. ### Document List ``` +--[ Attached Documents ]-------------------------------------------------+ | Type | Document | Date | Source | |----------------+----------------------------------+---------+------------| | Certificate | MPharm (Hons) 2:1 | 2015 | UEA | | Registration | GPhC Pharmacist Registration | 2016 | GPhC | | Certificate | Mary Seacole Programme (78%) | 2018 | NHS LA | | Results | A-Levels: Maths A*, Chem B, | 2011 | Highworth | | | Politics C | | Grammar | | Research | Drug Delivery & Cocrystals | 2015 | UEA | | | (75.1% Distinction) | | | +-------------------------------------------------------------------------+ ``` ### Document Type Icons Small document icons from Lucide: - `FileText` for certificates - `Award` for registrations - `GraduationCap` for academic results - `FlaskConical` for research ### Expanded Document Preview ``` MPharm (Hons) 2:1 - University of East Anglia |-- Type: Academic Qualification |-- Date Awarded: 2015 |-- Institution: University of East Anglia, Norwich |-- Classification: Upper Second-Class Honours (2:1) |-- Duration: 2011 - 2015 (4 years) |-- Research: Drug delivery and cocrystals | Grade: 75.1% (Distinction) |-- Notes: MPharm is a 4-year integrated Master's degree required for pharmacist registration in the UK. ``` The preview panel uses the same tree-indented structure as the Investigations expanded view, maintaining visual consistency across the PMR interface.